FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 4:15 AM GMTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel Medical Dialogues Bureau28 July 2019 3:47 AM GMTSales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
Pfizer gets USFDA approval for Fragmin to treat blood clot in pediatric patients Farhat Nasim19 May 2019 4:15 AM GMTThe efficacy of Fragmin in children was based on a single trial with 38 pediatric patients with symptomatic deep vein thrombosis and/or pulmonary...
Vaccine and blood thinner help drive Pfizer to quarterly earnings beat Medical Dialogues Bureau1 May 2019 6:37 AM GMTPfizer Inc on Tuesday reported a first-quarter profit that beat Wall Street estimates and slightly raised its 2019 earnings forecast, as the company...
JnJ, Bayer settles Xarelto lawsuits for 775 million Dollar Farhat Nasim27 March 2019 6:54 AM GMTLawsuits over Xarelto began piling up in 2014 and the companies had so far won all six trials over Xarelto's alleged bleeding risk.U.S: Bayer AG and...
France fines Johnson and Johnson 29.6 million dollars over painkiller patch Ruby Khatun Khatun21 Dec 2017 4:45 AM GMTPARIS: France's competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.6 million) on Wednesday after it ruled...
Delhi HC allows Natco, Alembic to Export Rivaroxaban of Bayer savita thakur thakur10 March 2017 4:15 AM GMTNEW DELHI: In a recent order passed by Delhi High Court, the court has granted the permission to Indian pharmaceuticals companies, Alembic and Natco...